Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lonsurf and G-CSF in Metastatic Colorectal Cancer
NCT04166604Phase 2Active, not recruiting
- Sponsor
- GERCOR
- Start
- May 2020
- Primary completion
- Nov 2023
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of granulocyte colony-stimulating factor in colorectal cancer (metastatic) (mCRC), sponsored by GERCOR. Started May 2020; status: active, not recruiting.
02
Drugs
granulocyte colony-stimulating factor
03
Conditions
colorectal cancer (metastatic) (mCRC)
Beyond the preview
Go deeper on NCT04166604.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04166604.